Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome

Creative Commons License

Beğenik H., Soyoral Y., Erkoc R., Emre H., TAŞKIN A., Tasdemir M., ...More

REDOX REPORT, vol.18, no.3, pp.107-112, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 3
  • Publication Date: 2013
  • Doi Number: 10.1179/1351000213y.0000000048
  • Journal Name: REDOX REPORT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.107-112
  • Bezmialem Vakıf University Affiliated: Yes


Objectives: Some studies have indicated the pathophysiological importance of reactive oxygen species (ROS) in patients with nephrotic syndrome. Myeloperoxidase (MPO) is a leukocyte-derived enzyme-generating ROS that has been proposed to exert a wide array of pro-atherogenic effects throughout all stages of the atherosclerotic process. The aim of this study was to investigate the serum malondialdehyde (MDA) levels, MPO and catalase activities in patients with adult nephrotic syndrome.